Science Friday

Covering the outer reaches of space to the tiniest microbes in our bodies, Science Friday is the source for entertaining and educational stories about science, technology, and other cool stuff.

  1. Searching for dark matter, deep in the Earth

    1 G FA

    Searching for dark matter, deep in the Earth

    Deep in an active nickel mine near Sudbury, Ontario, researchers are installing and calibrating a set of sensitive detectors. They hope that the location roughly 6,800 feet underground will screen out much of the ordinary radiation and cosmic rays felt on the surface, and allow their detectors to sense tiny disturbances caused by a dark matter particle passing close to the nucleus of one of the germanium atoms in a target material. If successful, the SuperCDMS SNOLAB experiment may shed some light on the nature of dark matter, an unseen something that is thought to make up around 85% of the matter in the universe. Priscilla Cushman, a physicist who has been working on the project for over 20 years, joins Host Flora Lichtman to describe the hunt, the timeline of the experiment, and the big unknowns facing the SuperCDMS team.  Guest:  Dr. Priscilla Cushman is spokesperson for the SuperCDMS SNOLAB experiment, and a professor in the School of Physics and Astronomy at the University of Minnesota. Other episodes you may enjoy: Listening for the cosmic ‘dark ages,’ from the lunar far side Most Powerful Neutrino Ever Is Detected In the Mediterranean Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-4-SCIFRI

    15 min
  2. What is ibogaine, and why is it in the news?

    6 GG FA

    What is ibogaine, and why is it in the news?

    In mid-April, President Trump issued an executive order to set aside funding and loosen the bureaucratic process at the FDA to fast-track psychedelic therapy research. One obscure psychedelic got a particularly bright spotlight: ibogaine. Originating from the root bark of the iboga plant of central Africa, the psychedelic has shown promise for curbing opioid addiction and treating PTSD. But it also can be risky to take, and hasn’t made it to the medical mainstream like psilocybin or ketamine. So what’s the story with this drug?  Joining Host Flora Lichtman to talk about its history is neurologist and pharmacologist Deborah Mash, who secured the first FDA approval for clinical trials involving ibogaine in the 1990s. And to tell us how it fits in with the growing interest in medical psychedelics is Jane Hu, journalist for The Microdose newsletter. (Disclosure: Deborah Mash is founder and CEO of a company that’s developing a therapeutic drug based on ibogaine.)  Guests:  Jane C. Hu is a journalist for the psychedelic science newsletter The Microdose, based in Seattle, WA. Dr. Deborah Mash is professor emeritus of neurology and molecular and cellular pharmacology at the University of Miami School of Medicine. She is the also founder and CEO of DemeRx. Other episodes you may enjoy: How One Gene Affects Alzheimer’s Risk Is This PTSD Treatment Too Good To Be True? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-4-SCIFRI

    19 min

Valutazioni e recensioni

4,8
su 5
4 valutazioni

Descrizione

Covering the outer reaches of space to the tiniest microbes in our bodies, Science Friday is the source for entertaining and educational stories about science, technology, and other cool stuff.

Altro da WNYC

Potrebbero piacerti anche…